下面这篇文章里面包含了Current Proposals for the Treatment of GM2 Gangliosidoses，在第7部分明确表示：
“Although some of these developments have been translated to clinical trials [91–94] (Table 2), there is not an approved treatment for TSD, SD, or AB variant yet.”
“尽管部分研究项目已经进入临床试验，但TSD, SD, 或 AD变异目前尚无获批的有效疗法。”
Leal AF, Benincore-Flórez E, Solano-Galarza D, Garzón Jaramillo RG, Echeverri-Peña OY, Suarez DA, Alméciga-Díaz CJ, Espejo-Mojica AJ. GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. Int J Mol Sci. 2020 Aug 27;21(17):6213. doi: 10.3390/ijms21176213. PMID: 32867370; PMCID: PMC7503724.
1 个回复
倘若邂逅
题主您好，帮您查了一下，目前尚无有效疗法。
下面这篇文章里面包含了Current Proposals for the Treatment of GM2 Gangliosidoses，在第7部分明确表示：
“Although some of these developments have been translated to clinical trials [91–94] (Table 2), there is not an approved treatment for TSD, SD, or AB variant yet.”
“尽管部分研究项目已经进入临床试验，但TSD, SD, 或 AD变异目前尚无获批的有效疗法。”
Leal AF, Benincore-Flórez E, Solano-Galarza D, Garzón Jaramillo RG, Echeverri-Peña OY, Suarez DA, Alméciga-Díaz CJ, Espejo-Mojica AJ. GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. Int J Mol Sci. 2020 Aug 27;21(17):6213. doi: 10.3390/ijms21176213. PMID: 32867370; PMCID: PMC7503724.
然后帮题主查看了一下正在进行的临床试验项目：https://clinicaltrials.gov/ct2/results?cond=&term=Sandhoff%20disease
病毒载体试验正在开展中，但目前并未公开任何实际结果：A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease